An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: Primary objective: To determine the efficacy of a candidate antiviral on time to virological cure compared to standard of care within 14 days of randomisation Secondary objectives: • To determine the safety of the antiviral • To determine the clinical benefit of the antiviral over placeb...

Descripción completa

Detalles Bibliográficos
Autores principales: McMahon, James H., Lau, Jillian S. Y., Roney, Janine, Rogers, Benjamin A., Trubiano, Jason, Sasadeusz, Joseph, Molton, James S., Gardiner, Bradley, Lee, Sue J., Hoy, Jennifer F., Cheng, Allen, Peleg, Anton Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552590/
https://www.ncbi.nlm.nih.gov/pubmed/33050947
http://dx.doi.org/10.1186/s13063-020-04766-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552590/
https://www.ncbi.nlm.nih.gov/pubmed/33050947
http://dx.doi.org/10.1186/s13063-020-04766-5

Ejemplares similares